Robots are absolutely useful, and major companies are building out massive robotics facilities to accelerate drug development. The point is that it's not a magi

Robots are absolutely useful, and major companies are building out massive robotics facilities to accelerate drug development. The point is that it's not a magic solution. It still takes a bunch of staff to run, and (much less appreciated) it takes a different mindset to be maximally useful. For example, maybe instead of doing a dozen informative but slightly complex assays, you do 1000 less useful but less complex assays. The end result might be just as useful if not more, but you have to structure your experiment differently. It's unlikely that technology will play out the same way in biotech as it has in pure tech. I'm heavily invested in the idea that it will be immensely useful, but given the different constraints and problem space I think the trajectory will be different.